Research

  • Feltri Receives Funding to Develop Therapy for MS
    5/24/21

    Research by M. Laura Feltri, MD, that seeks to design and develop a therapy for multiple sclerosis (MS) — leveraging a novel drug target discovered by Feltri’s team — has received a $250,000 investment from the Empire Discovery Institute (EDI).

  • Neuroscience Research Day Features 48 Presentations
    5/17/21

    Forty-eight oral and poster presentations were showcased at the 14th annual Buffalo Neuroscience Research Day of the neuroscience program and the Buffalo Chapter of the Society for Neuroscience (SfN).

  • Studies Focus on How Brain Limits Remyelination in MS
    4/16/21

    A pair of research studies led by Fraser J. Sim, PhD, associate professor of pharmacology and toxicology, reveal important new findings as to how regeneration of myelin in multiple sclerosis (MS) fails and, potentially, more efficient ways to treat it.

  • 48 Original Projects Featured at Student Research Forum
    3/22/21

    The research projects, from 48 aspiring physician-scientists, were presented at the 2021 Virtual Medical Student Research Forum.

  • Students Share Findings During GGB Research Day
    1/29/21

    Students and laboratories affiliated with the Genetics, Genomics and Bioinformatics graduate program (GGB) shared their findings during the seventh annual GGB Research Day.

  • Four MD-PhD Students Earned NIH F30 Fellowships in 2020
    12/22/20

    Four students in the MD-PhD Program have received prestigious fellowships from the National Institutes of Health (NIH) in 2020.

  • Seizure Drug Provides Relief for Severe Pregnancy Nausea
    12/7/20
    A rare, debilitating condition in pregnancy that causes nausea and vomiting so severe that some women end up terminating their pregnancies can be effectively treated with the seizure drug gabapentin.
  • Time Window Narrowed for Krabbe Disease Treatment
    12/4/20

    Researchers at the Jacobs School of Medicine and Biomedical Sciences have published a paper that is helping to define the best time to give a specific treatment to infants born with Krabbe disease (KD). 

  • Research Studies Progression of Neurodegeneration in MS
    11/17/20

    Jacobs School of Medicine and Biomedical Sciences researchers Richard W. Browne, PhD, and Robert Zivadinov, MD, PhD, are investigators for a $957,000 grant from the U.S. Army Medical Research and Development Command to explore the progression of neurodegeneration in multiple sclerosis (MS).